Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-23-003731

Chief Operating Officer acquired 26,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barton Russell Chief Operating Officer 2023-01-17 Grant or award +26,700 26,700 D
Derivatives
Barton Russell Chief Operating Officer 2023-01-17 Grant or award · Employee Stock Option (right to buy) +120,200 120,200 D
Loading xslF345X03/doc4.xml…